Liver Disease Diagnosis
Total Trials
9
As Lead Sponsor
6
As Collaborator
3
Total Enrollment
526
NCT01579162
Intra-Individual Reproducibility of the Non-Invasive Assessment of the Portal Circulation
Phase: N/A
Role: Lead Sponsor
Start: Jan 31, 2012
Completion: Apr 30, 2015
NCT03087968
Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124
Phase: Early Phase 1
Start: Jul 31, 2016
Completion: Sep 13, 2017
NCT03294941
The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function and Physiology
Phase: Phase 2
Start: Dec 8, 2017
Completion: Sep 11, 2019
NCT03583996
The SHUNT-V Study for Varices
Start: Jan 23, 2019
Completion: Oct 22, 2022
NCT04664621
HepQuant to Predict Hepatic Encephalopathy After TIPS
Role: Collaborator
Start: Feb 25, 2020
Completion: Sep 30, 2021
NCT06144827
A Pilot Study For Patients Receiving Radiation Therapy for Liver Cancer
Start: Jan 31, 2025
Completion: Jan 31, 2028
NCT07060547
Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease
Start: Jun 10, 2025
Completion: Mar 31, 2032
NCT06899152
HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer
Start: Jul 16, 2025
Completion: Jul 31, 2031
NCT07009132
Cholate Clearance in Fontan and Heart Failure
Start: Aug 4, 2025
Completion: Dec 31, 2031
Loading map...